|
PRKDC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.141520E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.825100E-04 |
| Normal-vs-Stage2 |
3.861600E-01 |
| Normal-vs-Stage3 |
9.424400E-01 |
| Normal-vs-Stage4 |
4.590800E-01 |
| Stage1-vs-Stage2 |
3.136400E-01 |
| Stage1-vs-Stage3 |
3.218500E-02 |
| Stage1-vs-Stage4 |
6.243200E-01 |
| Stage2-vs-Stage3 |
4.789000E-01 |
| Stage2-vs-Stage4 |
8.365600E-01 |
| Stage3-vs-Stage4 |
4.653800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.891590E-02 |
| Normal-vs-AfricanAmerican |
6.877200E-03 |
| Normal-vs-Asian |
1.528600E-01 |
| Caucasian-vs-AfricanAmerican |
4.024800E-01 |
| Caucasian-vs-Asian |
4.717800E-01 |
| AfricanAmerican-vs-Asian |
5.647800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23089999999981E-05 |
| Normal-vs-Female |
1.385170E-01 |
| Male-vs-Female |
4.03500000000223E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.510300E-02 |
| Normal-vs-Extreme_Weight |
2.77910000001658E-06 |
| Normal-vs-Obese |
9.086600E-01 |
| Normal-vs-Extreme_Obese |
1.080110E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.068580E-01 |
| Normal_Weight-vs-Obese |
2.545200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.571200E-01 |
| Extreme_Weight-vs-Obese |
4.017200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.128800E-01 |
| Obese-vs-Extreme_Obese |
2.694300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.442000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.838400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.038670E-03 |
| Normal-vs-Age(81-100Yrs) |
5.628600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.673360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.568300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.010000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.772230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.834200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.643200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52004999999233E-05 |
| Normal-VS-Type2 PRCC |
2.202600E-01 |
| Normal-VS-KIRP CIMP |
1.107620E-01 |
| Normal-VS-Unclassified PRCC |
8.582000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.191500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.550400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.055400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.505700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.779600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.055810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.173500E-04 |
| Normal-vs-N1 |
2.749200E-01 |
| Normal-vs-N2 |
3.052000E-01 |
| N0-vs-N1 |
2.106100E-02 |
| N0-vs-N2 |
2.596400E-03 |
| N1-vs-N2 |
5.895400E-01 |
|
|
